| 摘要 |
<p>The invention provides a novel prostate cell-surface antigen, designated Prostae Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.</p> |
